Cardiome Pharma Corporation (CRME) Climbed 5.04% or 0.07 To Price $1.46 On Monday

Cardiome Pharma Corporation (CRME) climbed 5.04% or 0.07 to $1.46. It is about 46729 shares traded, which is 61.98% compare to the average total volume 75396. The market cap of CRME is $50.57 million. The year to date change is -11.46%. The 52 week price range is from $1.29 to $4.84. Price of CRME have changed -2.11% during last week. It have changed -13.13% over last month, -6.08% over last 3 months, -64.36% over last 6 months and -52.72% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRME is 1.50. It is 2.74% above current price. The 200-day Moving Averages for CRME is 2.67. It is 82.88% above current price. The 52-week High is 4.84. It is 231.51% from the current price. The 52-week Low is 1.29. It is -11.64% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CRME is 1.53 on 2018-01-31. Short % to float is 0.30%. There are some statistics of CRME. It is has market cap $50.57 million. The share outstanding is 34.64 million. The average volume is 75396. The revenue is 23.99M. It has 101.70M cash and 19.39M in debt. The gross profit is 17.29M. The percent of top 15 Institution holding is 45.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRME is -85.43%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRME is -37.20%.


Share this post